TNGX - Tango Therapeutics GAAP EPS of -$0.32 misses by $0.04 revenue of $5.43M misses by $2.81M
2024-03-18 07:11:07 ET
More on Tango Therapeutics
- Tango Therapeutics: Making Its Way Into Clinic With 4 Innovative Cancer Drugs
- Tango Therapeutics Must Produce Its Own Data To Justify Its Valuation
- Seeking Alpha’s Quant Rating on Tango Therapeutics
- Historical earnings data for Tango Therapeutics
- Financial information for Tango Therapeutics